EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RB family tumor suppressor activity may not relate to active silencing of E2F target genes



RB family tumor suppressor activity may not relate to active silencing of E2F target genes



Cancer Research 74(18): 5266-5276



The retinoblastoma protein pRB and its two homologs p130 and p107 form the family of pocket proteins and play a major role in cell-cycle regulation and suppression of human and mouse tumorigenesis. Pocket proteins regulate the activity of E2F transcription factors during G1-S transition. Two mechanisms have been described: (i) pocket protein binding blocks the transactivation domain of activator E2Fs, inhibiting E2F-dependent transcription and (ii) E2F-bound pocket proteins can recruit chromatin remodeling proteins containing an LxCxE motif (x encoding any amino acid), resulting in active repression of E2F target genes. To investigate the importance of pRB's LxCxE-interacting motif in cell-cycle control and tumor suppression, we generated mouse embryonic fibroblasts and mice expressing a mutant pRB protein carrying an asparagine for phenylalanine substitution at position 750, abrogating LxCxE binding. Because p130 may compensate for loss of pRB, we studied pRB(N750F) activity in the presence and absence of p130. The pRB-LxCxE interaction was not required for cell-cycle arrest upon mitogen deprivation and cell-cell contact, but did contribute to RAS(V12)- and radiation-induced cell-cycle arrest. Remarkably, the pRB-LxCxE interaction was not required for suppression of in vitro and in vivo transformation, even in the absence of p130. These results indicate that pRB's tumor suppressor activity is not effectuated by active silencing of E2F target genes, but rather by regulation of activator E2Fs or another unidentified mechanism. Furthermore, the in vitro response of pocket protein-perturbed cells to mitogen deprivation and cell-cell contact seems a better predictor of tumor development than the response to ectopic RAS(V12) expression. Cancer Res; 74(18); 5266-76. ©2014 AACR.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333541

Download citation: RISBibTeXText

PMID: 25056122

DOI: 10.1158/0008-5472.CAN-13-3706



Related references

Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer. Epigenetics 6(5): 610-622, 2011

Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leukemia Research 30(3): 303-312, 2005

The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Molecular and Cellular Biology 28(21): 6632-6645, 2008

Penn study on silencing of tumor suppressor gene suggests new target for lymphoma. 2011

Epigenetic silencing of tumor suppressor genes in pancreatic cancer. Journal of Gastrointestinal Cancer 42(2): 93-99, 2011

Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential. Biochimica et Biophysica Acta 1865(2): 275-288, 2016

Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. Plos One 7(3): E33284-E33284, 2012

Id1 overexpression is independent of repression and epigenetic silencing of tumor suppressor genes in melanoma. Epigenetics 5(5): 410-421, 2011

Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. Stem Cells 28(8): 1349-1354, 2011

Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors. Genes & Development 27(20): 2221-2226, 2013

Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proceedings of the National Academy of Sciences of the United States of America 112(37): E5199-E5207, 2016

Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism. Proceedings of the National Academy of Sciences of the United States of America 103(20): 7741-7746, 2006

Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Molecular Carcinogenesis 52(6): 475-487, 2013

Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines. Cancer Research 68(18): 7258-7263, 2008

Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Pancreas 36(4): E32-E39, 2008